X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


Latest Post

May 16, 2019

Delivering Macromolecules: Challenges Associated with the Delivery of Biologic Drugs

Biologic drugs, rather than being synthesized from other compounds, are generally made using human or animal proteins. At the molecular level, they’re usually larger and much more complex than regular drugs. Routine oral administration of biologics has not been mastered as there is enzymatic and pH-dependent degradation of drugs in the stomach and intestines. Low permeability of epithelial cells that line the gastrointestinal tract means that proteins and peptides typically have extremely low bioavailability in the range of around 0-2% when taken by mouth.
Victoria Morgan

Victoria Morgan

Director, Segment Marketing, Biologics

Previous Posts
Leo Posner of Johnson & Johnson presenting at the PDA Combo Workshop

April 03, 2019

The Challenges of Combination Products

Fran DeGrazio

Fran DeGrazio

VP, Technical Services and Scientific Affairs

B2 Coating Stoppers

March 04, 2019

The Smart Solution When Silicone Oil is an Issue

Simon Meurer

Simon Meurer

Manager, TCS, Commercial

FluroTec Barrier Film Coating

January 29, 2019

Effective Drug Protection for Plungers in a Prefillable Syringe System

Christa Jansen-Otten

Christa Jansen-Otten

Director, Product Mgmt, PFS & Delivery

Introducing Integrated Solutions

October 08, 2018

Introducing Integrated Solutions

Deirdre Swinden

Deirdre Swinden

Director, Marketing Communications

Load more